comcast cares

Tech company to grant funds to Houston-area BIPOC small business owners

Comcast is looking out for the one-third of businesses in the Houston metro area that are minority-owned. Photo courtesy of comcast.

Comcast, the telecom, media, and entertainment conglomerate, is awarding $1 million in grants to small businesses in Houston owned by entrepreneurs who are Black, indigenous or people of color (BIPOC).

In all, 100 grants of $10,000 each will be given to BIPOC-owned small businesses in Houston. Local businesses can apply for the grants March 1-14. Grant recipients will be announced in April and awarded in May.

"Unfortunately, many small businesses in Houston were not able to withstand the many months of suppressed revenues [amid the pandemic]. While we remain optimistic about our economic recovery, public-private partnerships will play a vital role in minimizing the disruptions that so many small businesses, specifically minority-owned businesses, are facing," says Vice Mayor Pro Tem Martha Castex-Tatum, who chairs the Houston City Council's Economic Development Committee.

The Houston grants are part of a $5 million investment fund sponsored by Comcast RISE, which launched last year to provide resources to BIPOC-owned small businesses around the country. Under this initiative, grants also will be awarded in Atlanta, Chicago, Detroit, and Philadelphia.

Studies show BIPOC-owned small businesses have been particularly hard hit by the pandemic, and recent research by JPMorgan Chase Institute found that Atlanta, Chicago, Detroit, Houston and Philadelphia were among the top markets for sharp declines in local spending. Additionally, the majority of applications for the marketing and technology services component of Comcast RISE are from these five cities.

To qualify for a Comcast RISE grant in Houston, a BIPOC-owned small business:

  • Must be located in either Harris County or Fort Bend County.
  • Must have been in business for at least three years.
  • Must employ no more than 25 people.

To drive outreach about the program and provide support, training, and mentorship, Comcast also has awarded more than $2 million to six Houston business groups: Houston Hispanic Chamber of Commerce, Greater Houston Black Chamber, Asian Chamber of Commerce, Greater Houston LGBT Chamber of Commerce, Houston East End Chamber, and Cámara de Empresarios Latinos de Houston.

"Small businesses have always played an integral role in Houston's growth and future," Ralph Martinez, senior vice president for Comcast's Houston region, says in a February 9 release. "In the midst of the pandemic, these entrepreneurs provided many of the services and resources that have kept our communities up and running."

About one-third of businesses in the Houston metro area are minority-owned. Among largest metros in the U.S., Houston ranks fifth for the percentage of minority-owned startups (30.45 percent).

Comcast RISE is part of a broader $100 million diversity, equity, and inclusion initiative that launched last summer. In June, Comcast NBCUniversal announced a multiyear plan to allocate $75 million in cash and $25 million worth of media over the next three years to fight injustice and inequality against any race, ethnicity, gender identity, sexual orientation, or ability.

Trending News

Building Houston

 
 

Tvardi Therapeutics Inc. has fresh funds to support its drug's advancement in clinical trials. Photo via Getty Images

A Houston-based clinical-stage biopharmaceutical company has raised millions in its latest round.

Tvardi Therapeutics Inc. closed its $74 million series B funding round led by new investors New York-based Slate Path Capital, Florida-based Palkon Capital, Denver-based ArrowMark Partners, and New York-based 683 Capital, with continued support and participation by existing investors, including Houston-based Sporos Bioventures.

"We are thrilled to move out of stealth mode and partner with this lineup of long-term institutional investors," says Imran Alibhai, CEO at Tvardi. "With this financing we are positioned to advance the clinical development of our small molecule inhibitors of STAT3 into mid-stage trials as well as grow our team."

Through Slate Path Capital's investment, Jamie McNab, partner at the firm, will join Tvardi's board of directors.

"Tvardi is the leader in the field of STAT3 biology and has compelling proof of concept clinical data," McNab says in the release. "I look forward to partnering with the management team to advance Tvardi's mission to develop a new class of breakthrough medicines for cancer, chronic inflammation, and fibrosis."

Tvardi's latest fundraise will go toward supporting the company's products in their mid-stage trials for cancer and fibrosis. According to the release, Tvardi's lead product, TTI-101, is being studied in a Phase 1 trial of patients with advanced solid tumors who have failed all lines of therapy. So far, the drug has been well-received and shown multiple durable radiographic objective responses in the cancer patients treated.

Dr. Keith Flaherty, who is a member of Tvardi's scientific advisory board and professor of medicine at Harvard Medical School, offered his support of the company.

"STAT3 is a compelling and validated target. Beyond its clinical activity, Tvardi's lead molecule, TTI-101, has demonstrated direct downregulation of STAT3 in patients," he says in the release. "As a physician, I am eager to see the potential of Tvardi's molecules in diseases of high unmet medical need where STAT3 is a key driver."

Trending News